Community-reported insights only, not medical advice. Data recency varies by source; check timestamps and confidence before making treatment decisions.

← Back to Strains

Bubba Kush

Strain Profile & Patient Reviews

flower
by Medropharm

Based on 8 patient discussions recently (last 90 days).

Last community signal: 25 Apr 2026. Confidence: low (<15 recent mentions).

Frequently Mentioned (Last 30 Days)

mutedstickygassy
Recent Score
45
All-Time Avg: 45

Actionable Profile

Fast summary for decision support. These are community signals, not clinical advice.

Likely Benefits

Most frequently reported positive outcomes from recent community mentions.

stickygassy

Likely Side Effects

Community flags that can indicate tolerability risks.

No recurring side-effect keyword cluster detected in current recent flags. Check confidence and recency before trial.

Community Sentiment

40% positive, 40% mixed, 20% negative from 5 unique users (90d).

Trend Direction

Stable: recent score is close to long-term baseline.

Evidence sources: Discord community discussions (deduped by user).

Last community signal: 25 Apr 2026 | Profile generated:

Patient Consensus (Last 90 Days)

Aggregated sentiment from unique patients. Multiple comments from the same user are combined into a single vote.

40% Positive
40% Mixed
20% Negative
Based on the opinions of 5 unique patients.

Technical Specifications

THC Content
22.0%
Country of Origin
Switzerland
Cultivar
Bubba Kush
Lineage
OG Kush x Afghan Landrace

Terpene Profile

Caryophyllene Myrcene
D-Limonene
Find similar strains by chemical profile →

Recent Quality Trend

7-day rolling average of patient-reported scores. Use as directional community evidence, not clinical proof.

Line chart showing recent 7-day rolling average sentiment scores for this strain over time, on a 0 to 100 scale.

Month-by-Month Quality

Average patient-reported score by month. This indicates consistency in reports over time.

Bar chart showing monthly average sentiment scores for this strain on a 0 to 100 scale.